SLU Graduate Student Advances Research Toward New Non-Opioid Pain Treatments

Kyle Oberkrom, a graduate student at Saint Louis University School of Medicine, is the first author of a new study published in Pain, a leading international journal in pain research.
Funded by the National Institutes of Health, the study uncovers new molecular and cellular mechanisms linking cholesterol-derived lipids (oxysterols) and GPR183 to pain sensitization, supported by findings in human surgical tissues.
Oberkrom is a Ph.D. candidate working in the laboratory of Daniela Salvemini, Ph.D., a professor of pharmacology and physiology, and the work advances the lab’s efforts to develop novel, non-opioid pain therapeutics targeting neuroimmune signaling. The team conducted the study in collaboration with investigators at the NIH, Northwestern University, and the laboratory of Christopher Arnatt, Ph.D., a SLU associate professor of chemistry and pharmacology and physiology.